Related Experiment Video
Updated: May 6, 2026

07:27
Implantation of Total Artificial Heart in Congenital Heart Disease
Published on: July 18, 2014
24.6K
Artificial Intelligence in Congenital Heart Disease: Current State and Prospects
Pei-Ni Jone1, Addison Gearhart2, Howard Lei3
1Section of Pediatric Cardiology, Department of Pediatrics, Lurie Children's Hospital of Chicago, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
JACC. Advances
|June 28, 2024
Summary
Artificial intelligence (AI) presents opportunities to improve congenital heart disease care. However, AI is currently underutilized in clinical settings for diagnosis, prognosis, and management, highlighting a need for strategic deployment.
Area of Science:
- Cardiology
- Medical Informatics
- Artificial Intelligence
Background:
- Big data era offers opportunities for artificial intelligence (AI) in healthcare.
- Congenital heart disease (CHD) patient care can be optimized using AI.
- Significant underutilization of AI in clinical CHD diagnosis, prognosis, and management exists.
Purpose of the Study:
- To describe the current state of AI in congenital heart disease.
- To review challenges and discuss opportunities for AI in CHD.
- To identify top priorities for AI-based deployment in CHD.
Main Methods:
- Literature review on AI applications in CHD.
- Analysis of current AI utilization in clinical practice.
- Identification of barriers and facilitators for AI adoption.
Main Results:
- AI offers potential for enhanced CHD care but is underused.
- Key challenges include data integration, validation, and clinical workflow.
- Opportunities lie in predictive modeling, personalized treatment, and improved outcomes.
Conclusions:
- Strategic AI deployment is crucial for advancing CHD care.
- Addressing current challenges will unlock AI's full potential in CHD.
- Prioritizing AI applications can optimize diagnosis, prognosis, and management for CHD patients.
Related Concept Videos
Cardiomyopathy II: Dilated Cardiomyopathy
802
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
802
Cardiomyopathy V: Interprofessional Care
762
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
762

